Refer to the Brain Tumor and Neuro-Oncology Center

HOSPITAL
University Hospitals Seidman Cancer Center

APPOINTMENT LINE
Please call 216-844-6054, option 3.
For hospital transfers, please call 216-844-1111

OUR TEAM

Andrew E. Sloan, MD, FACS
Professor & Vice Chairman, Department of Neurosurgery
Peter D. Cristal Chair of Neurosurgical Oncology
Director, Brain Tumor & Neuro-Oncology Center
Director, Center of Excellence, Translational Neuro-Oncology

Brian Bonder, MD
Assistant Professor of Medical Oncology

Serah Choi, MD
Assistant Professor of Radiation Oncology
Director of Brain & Spine Radiosurgery

Alia Hdeib, MD
Assistant Professor of Neurosurgery
Director of Spinal Metastasis Program

Tiffany Hodges, MD
Assistant Professor of Neurosurgery

Conditions Treated

• Primary brain tumors: Glioblastoma multiforme (GBM) , astrocytoma, oligodendroglioma, ependymoma, hemangioblastoma, meningioma, schwanoma, pituitary adenoma, medulloblastoma, pilocytic astrocytoma, ganglioglioma, pleomorphic xanthrocytoma (PXA)
• Pineal neoplasms
• Skull base tumors (chordoma, chondrosarcoma)
• Metastatic brain tumors
• Leptomeningeal metastasis
• Spine tumors (primary and metastatic)
• Peripheral nerves tumors
• Neurofibromatosis
• Radiation necrosis of the brain

Therapies

• Image-guided (stereotactic) surgery
• Skull base surgery
• Minimally invasive techniques (keyhole surgery)
• Laser interstitial thermotherapy (LITT) and stereotactic laser ablation (SLA)
• Stereotactic radiosurgery: Gamma Knife® radiosurgery for brain tumorss
• Proton therapy
• Convection enhanced delivery
• Chemotherapy
• Radiotherapy
• Immunotherapy
• Stem cell therapies
• Cell-based therapies
• Gene therapy
• Antiangiogenic therapy
• Hyperbaric oxygen for radiation necrosis

Distinguishing Features

• Part of NCI-designated Case Comprehensive Cancer Center
• Multidisciplinary consultation with disease-specific tumor boards
• Personalized therapies incorporating genetic and genomic analysis and genomic tumor board
• National leadership in clinical trials: Adult Brain Tumor Consortium (ABTC) and NRG
• 3T intraoperative MRI (iMRI) and Surgical Theater Rehearsal Platform for patient-specific surgical rehearsal
• Advanced imaging including MRI, MRA, PET-MRI and MR fingerprinting
• Genetic risk assessment to guide preventive strategies in cancer-prone families
• Validated nomograms for patient-specific prognosis
• Supportive and Integrative Oncology and Adolescent and Young Adult (AYA) cancer programs